SVS PSO VQI Regional Meeting: Great Lakes Vascular Study Group

Cleveland, OH US
November 11, 2022

This is a private online course, and registrations are not being accepted.


The Society for Vascular Surgery Patient Safety Organization (SVS PSO) is to improve the quality, safety, effectiveness, and cost of vascular healthcare by collecting and exchanging information through regional quality improvement groups.

Professional Practice Gap

Each regional group is provided with benchmark reports to compare their center/region/national outcomes to focus on quality improvement to meet the mission of the SVS PSO.  Some examples include metrics on:

  • Length of stay (cost) 
  • Long-term follow-up of patients (quality)
  • Clinical outcomes, such as mortality and stroke (quality/safety)
  • Use of Statins and Antiplatelets to decrease mortality (effectiveness) 
  • Adherence to scientific guidelines to optimize patient care (quality/safety/effectiveness) 

By reviewing their benchmarks during these bi-annual meetings, each site and region can focus quality improvement efforts to improve and track their success over time. 

Learning Objectives

  • Use the VQI regional reports to establish quality improvement goals for the vascular patients (outcomes) and their center (process).
  • Interpret and compare each center’s VQI results to regional and national benchmarked data.
  • Learn, through group discussion, the VQI regional results to improve the quality of vascular health care by monitoring measurable performance indicators, SVS PSO evidence-based research, and outcomes.
  • Identify high-performing regional vascular centers to discuss variations in care and clinical practice patterns to improve outcomes and prompt quality improvement recommendations for vascular care patients.
  • Share of best practices/pathways of care.


The agenda is in the local time. 

TimeTopicCE Credit
12:00 pmWelcomeNo
12:05 pmLunchNo
1:05 pm

Regional Data Review and QI Proposal

Mohammad Eslami, MD
GLVSG Medical Director

2:35 pm

National VQI Update

Caroline Morgan, BSN
PSO Clinical Operations Associate

3:35 pm

AQC Update
John Moawad, MD

VQC Update
Fedor Lurie, MD

RAC Update
Michael Madigan, MD

Governing Council Update
Mohammad Eslami, MD

3:55 pmCase PresentationsNo
4:00 pmAdjournNo
Course summary
Available credit: 
  • 2.50 AMA PRA Category 1 Credits
  • 2.50 AOA Category 2­A
  • 2.50 CE Contact Hour(s)
  • 2.50 IBON
Course opens: 
Course expires: 
Event starts: 
11/11/2022 - 12:00pm CST
Event ends: 
11/11/2022 - 4:00pm CST
Cleveland Clinic
9500 Euclid Ave
Cleveland, OH 44195
United States

Accreditation Statements

  • DO: Des Moines University (DMU) is accredited by the American Osteopathic Association (AOA) to provide osteopathic continuing medical education for physicians. DMU designates this activity for a maximum of 2.5 AOA Category 2-A credits and will report CME and specialty credits commensurate with the extent of the physician’s participation in this activity.
  • MD: This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Iowa Medical Society (IMS) through the joint providership of Des Moines University (DMU) and the Society for Vascular Surgery Patient Safety Organization. DMU is accredited by IMS to provide continuing medical education for physicians. DMU designates this live activity for a maximum of 2.5 AMA PRA Category 1 Credit(s)TM. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
  • Nurse: Des Moines University is Iowa Board of Nursing approved provider #112. This live activity has been reviewed and approved for 2.5 continuing education contact hour(s). No partial credit awarded.
  • Other healthcare professionals: This live activity is designated for 2.5 AMA PRA Category 1 Credit(s)TM

Educational Grants

Thanks to the following companies for their generous financial support of this continuing education activity.

  • Cook Medical, LLC
  • W.L. Gore & Associates, Inc.


The planning committee member(s) and speaker(s) will disclose if any pharmaceuticals or medical procedures and devices discussed are investigational or unapproved for use by the U.S. Food and Drug Administration (FDA). The determination of educational content and the selection of speakers is the responsibility of the activity director. 

Click here to view the disclosures.


The information provided at this activity is for continuing education. It is not meant to substitute for the independent medical judgment of a healthcare provider relative to diagnostic and treatment options of a specific patient’s medical condition. The content of each presentation does not necessarily reflect the views of Des Moines University.

Available Credit

  • 2.50 AMA PRA Category 1 Credits
  • 2.50 AOA Category 2­A
  • 2.50 CE Contact Hour(s)
  • 2.50 IBON


Please login or Create an Account to take this course.

This is a private online course and registrations are not being accepted.